Cargando…
Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
Previous studies have shown that mithramycin A (MIT) is a promising candidate for the treatment of pancreatic carcinoma through inhibiting transcription factor Sp1. However, systemic toxicities may limit its clinical application. Here, we report a rationally designed formulation of MIT-loaded nanopa...
Autores principales: | Liu, Xu-Jie, Li, Liang, Liu, Xiu-Jun, Li, Yi, Zhao, Chun-Yan, Wang, Rui-Qi, Zhen, Yong-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5533565/ https://www.ncbi.nlm.nih.gov/pubmed/28769562 http://dx.doi.org/10.2147/IJN.S139507 |
Ejemplares similares
-
The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
por: Xu, Yuanyuan, et al.
Publicado: (2016) -
Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis
por: Zhou, Lin, et al.
Publicado: (2015) -
Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
por: Li, Mingguang, et al.
Publicado: (2012) -
Developing a Highly Stable PLGA-mPEG Nanoparticle Loaded with Cisplatin for Chemotherapy of Ovarian Cancer
por: Cheng, Lihua, et al.
Publicado: (2011) -
Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease
por: Xu, Ruiling, et al.
Publicado: (2020)